Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 mars 2023



Contactez-nous à info@labatec.com
Pour d’autres demandes, visitez notre page de contact. contact page.